Irritable bowel syndrome (IBS) is not a disease but a group of symptoms that affects 10 to 20 percent of the population in developed countries. IBS is also not 'all in the head' as has been commonly thought. In a review of the literature, Mayo Clinic gastroenterologist, Michael Camilleri, M.D., describes a renaissance in the understanding of the condition, dismissing the notion that symptoms are specific to a single cause. "Our goal is a better understanding of the mechanisms behind this syndrome. That way, we can foster individualized, specific treatment for patients with IBS."
Click here for new release
Sound bites are available in the downloads above
Expert title for broadcast cg: Dr. Michael Camilleri, Mayo Clinic Gastroenterologist